Pathobiology of anaplastic large cell lymphoma

Pier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, Claudio Agostinelli, Francesco Bacci, Elena Sabattini, Carlo Sagramoso, Roberto Piva, Fernando Roncolato, Giorgio Inghirami, Stefano A. Pileri

Research output: Contribution to journalArticle

Abstract

The authors revise the concept of anaplastic large cell lymphoma (ALCL) in the light of the recently updated WHO classification of Tumors of Hematopoietic and Lymphoid Tissues both on biological and clinical grounds. The main histological findings are illustrated with special reference to the cytological spectrum that is indeed characteristic of the tumor. The phenotype is reported in detail: the expression of the ALK protein as well as the chromosomal abnormalities is discussed with their potential pathogenetic implications. The clinical features of ALCL are presented by underlining the difference in terms of response to therapy and survival between the ALK-positive and ALK-negative forms. Finally, the biological rationale for potential innovative targeted therapies is presented.

Original languageEnglish
Article number345053
JournalAdvances in Hematology
Volume2010
DOIs
Publication statusPublished - 2010

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Pathobiology of anaplastic large cell lymphoma'. Together they form a unique fingerprint.

  • Cite this

    Piccaluga, P. P., Gazzola, A., Mannu, C., Agostinelli, C., Bacci, F., Sabattini, E., Sagramoso, C., Piva, R., Roncolato, F., Inghirami, G., & Pileri, S. A. (2010). Pathobiology of anaplastic large cell lymphoma. Advances in Hematology, 2010, [345053]. https://doi.org/10.1155/2010/345053